Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/tooltip-triangle.png. Accessed 28 April 2024.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/tooltip-triangle.png. Accessed April 28, 2024.
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/tooltip-triangle.png
Duration of Treatment With Vitamin K Antagonists in Symptomatic Venous Thromboembolism: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 April 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism: Cochrane systematic review
ID - 435694
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435694/1/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -